The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Zoghbi Huda Y since 2020.
This trader's CIK number is 1681643.
At the time of last reporting, Zoghbi Huda Y was the Director of Regeneron Pharmaceuticals, Inc.. (stock ticker symbol REGN).
Also see all insider trading activities at Regeneron Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | REGN | 0 | $0 | 1,117 | $1,005,300 | 1,117 | $437,774 |
| 2023 | REGN | 0 | $0 | 1,000 | $850,000 | 1,000 | $391,920 |
| 2022 | REGN | 0 | $0 | 2,000 | $1,350,000 | 2,000 | $783,840 |
| 2020 | REGN | 0 | $0 | 10,236 | $6,121,848 | 10,236 | $4,011,691 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-02 | REGN | Option Ex | 1,117 | 391.92 | 437,774 |
| 2024-01-02 | REGN | Sale | 1,117 | 900.00 | 1,005,300 |
| 2023-10-13 | REGN | Option Ex | 1,000 | 391.92 | 391,920 |
| 2023-10-13 | REGN | Sale | 1,000 | 850.00 | 850,000 |
| 2022-03-16 | REGN | Option Ex | 2,000 | 391.92 | 783,840 |
| 2022-03-16 | REGN | Sale | 2,000 | 675.00 | 1,350,000 |
| 2020-07-07 | REGN | Sale | 1,706 | 650.00 | 1,108,900 |
| 2020-07-07 | REGN | Option Ex | 1,706 | 391.92 | 668,615 |
| 2020-06-10 | REGN | Sale | 1,706 | 611.13 | 1,042,582 |
| 2020-06-11 | REGN | Sale | 1,706 | 625.00 | 1,066,250 |
| 2020-06-10 | REGN | Option Ex | 1,706 | 391.92 | 668,615 |
| 2020-06-11 | REGN | Option Ex | 1,706 | 391.92 | 668,615 |
| 2020-05-07 | REGN | Option Ex | 5,118 | 391.92 | 2,005,846 |
| 2020-05-07 | REGN | Sale | 5,118 | 567.43 | 2,904,116 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zoghbi Huda Y (Director of Regeneron Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.